18 mg tirzepatide TrimRX Tirzepatide Dosage Guide and Chart
Description
Please note that this article is intended for informational purposes only and should not be construed as medical advice

In the SURMOUNT-1 trial, participants on the highest dose (15 mg) lost an average of 20.9% of their body weight over 72 weeks

Medical Therapy: Mounjaro Side Effects

W., GlucagonLike Peptide 1 (GLP1) Receptor Agonists' Use During Pregnancy: Safety Data From Regulatory Clinical Trials, Diabetes, Obesity & Metabolism 27, no

Individuals taking tirzepatide (Mounjaro, Zepbound) may be eligible to donate plasma, but eligibility depends on several factors including the reason for use, overall health status, and individual donation center policies
And if you have missed more than 2 consecutive weeks, contact your provider
